Head to Head Comparison: Ceres Ventures (OTCMKTS:CEVE) vs. Option Care Health (NASDAQ:OPCH)

Option Care Health (NASDAQ:OPCH) and Ceres Ventures (OTCMKTS:CEVE) are both medical companies, but which is the superior business? We will compare the two businesses based on the strength of their dividends, earnings, institutional ownership, risk, valuation, profitability and analyst recommendations.

Insider and Institutional Ownership

98.1% of Option Care Health shares are held by institutional investors. 0.6% of Option Care Health shares are held by insiders. Comparatively, 0.1% of Ceres Ventures shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

Risk and Volatility

Option Care Health has a beta of 0.74, meaning that its share price is 26% less volatile than the S&P 500. Comparatively, Ceres Ventures has a beta of 2.72, meaning that its share price is 172% more volatile than the S&P 500.

Profitability

This table compares Option Care Health and Ceres Ventures’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Option Care Health	4.12%	16.90%	7.00%
Ceres Ventures	N/A	N/A	N/A

Analyst Recommendations

This is a summary of current recommendations and price targets for Option Care Health and Ceres Ventures, as provided by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Option Care Health	0	1	7	0	2.88
Ceres Ventures	0	0	0	0	0.00

Option Care Health presently has a consensus price target of $35.50, indicating a potential upside of 12.59%. Given Option Care Health’s stronger consensus rating and higher probable upside, research analysts plainly believe Option Care Health is more favorable than Ceres Ventures.

Valuation & Earnings

This table compares Option Care Health and Ceres Ventures”s gross revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Option Care Health	$5.00 billion	1.03	$211.82 million	$1.24	25.43
Ceres Ventures	N/A	N/A	N/A	N/A	N/A

Option Care Health has higher revenue and earnings than Ceres Ventures.

Summary

Option Care Health beats Ceres Ventures on 9 of the 10 factors compared between the two stocks.

About Option Care Health

Option Care Health, Inc. offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn’s disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders. It also offers treatments to manage the progression of neurological disorders, such as multiple sclerosis, duchenne muscular dystrophy, and other neurological disorder; infusion therapies for bleeding disorders, such as hemophilia and von Willebrand diseases; therapies for women with high-risk pregnancies; and other infusion therapies to treat various conditions, including pain management, chemotherapy, and respiratory medications, as well as nursing services. The company markets its services through patient referrals, including physicians, hospital discharge planners, hospital personnel, health maintenance organizations, and preferred provider organizations. Option Care Health, Inc. is headquartered in Bannockburn, Illinois.

About Ceres Ventures

Ceres Ventures, Inc., a development stage company, focuses on the research, development, and commercialization of clean technologies for the remediation of polluted water, soil, and air. Its technologies include BluFlow Nanoparticles, a proprietary system for formulating, producing, and deploying customizable absorbent nanoparticles to specific functionality for contaminant/chemical removal and extraction of valuable elements and compounds from water based solutions; BluFlow Advanced Ultrafiltration Technology, an automated process to recover water from waste or impure streams; and BluFlow Treatment System a water and wastewater treatment solution, which incorporates the BluFlow Nanoparticles and the BluFlow Advanced Ultrafiltration Technology to remove target elements, compounds, and pollutants, as well as purify water that may be suitable for reuse. Ceres Ventures, Inc.'s products are used in water and wastewater treatment and purification, contaminated groundwater treatment, industrial wastewater treatment, and valuable elements and compounds extraction applications. The company was formerly known as PhytoMedical Technologies, Inc. and changed its name to Ceres Ventures, Inc. in November 2011. Ceres Ventures, Inc. was founded in 2010 and is based in New York, New York.